Literature DB >> 16549898

Postthrombotic syndrome in children.

Marilyn J Manco-Johnson1.   

Abstract

The postthrombotic syndrome (PTS) is a clinical condition of limb pain along with physical findings that range from swelling to stasis ulcers following one or more episodes of deep vein thrombosis (DVT). While venous thromboembolism has recently gained increased recognition in children, the sequelae of limb thrombi are being recognized in a substantial proportion of affected children, and with varying degrees of severity. PTS is caused by both obstructed as well as refluxed venous blood flow, with combined effects of obstruction and reflux resulting in earlier, and more extensive symptoms. PTS can be diagnosed using an evaluation tool adapted from an international adult scale. Certain risk factors predispose children to PTS including elevations in factor VIII activity and D-dimer, clot occlusiveness, clot persistence, number of venous segments involved and duration of observation following DVT. Optimal prevention and treatment have not yet been determined, although antithrombotic therapy to facilitate rapid clot resolution, elevation, compression, moderate exercise and achievement of optimal body weight are likely to improve outcome. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549898     DOI: 10.1159/000090937

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 2.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.

Authors:  Neil A Goldenberg; Marco P Donadini; Susan R Kahn; Mark Crowther; Gili Kenet; Ulrike Nowak-Göttl; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

3.  Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patients.

Authors:  Sarah E Leary; Virginia L Harrod; Pedro A de Alarcon; Ulrike M Reiss
Journal:  J Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.289

4.  Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis.

Authors:  Christopher E Dandoy; Kamlesh U Kukreja; Ralph A Gruppo; Manish N Patel; Cristina Tarango
Journal:  Pediatr Radiol       Date:  2014-11-07

Review 5.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

6.  Deep vein thrombosis: thrombolysis in the pediatric population.

Authors:  Lindsey A Greene; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

7.  A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children.

Authors:  Neil A Goldenberg; Janette D Durham; R Knapp-Clevenger; Marilyn J Manco-Johnson
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

8.  TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.

Authors:  Irene L M Klaassen; Mandy N Lauw; Marianne D van de Wetering; Bart J Biemond; Saskia Middeldorp; Floor C H Abbink; Marc Bierings; D Maroeska M W Te Loo; Rob Pieters; Inge M van der Sluis; Wim J E Tissing; C Michel Zwaan; C Heleen van Ommen
Journal:  BMC Pediatr       Date:  2017-05-10       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.